HIV integration

HIV Integration is a crucial step in the life cycle of the Human Immunodeficiency Virus (HIV). This process involves the insertion of the viral DNA into the host cell's genome, which allows the virus to replicate and spread throughout the body.

Overview

HIV integration is facilitated by the viral enzyme integrase. After the virus enters a host cell, it uses its reverse transcriptase enzyme to convert its RNA into DNA. The newly formed viral DNA then interacts with the host cell's DNA, guided by the integrase enzyme. This results in the integration of the viral DNA into the host cell's genome, which allows the virus to use the host cell's machinery to replicate itself.

Mechanism

The mechanism of HIV integration involves several steps:

1. Viral Entry: The HIV virus binds to the CD4 receptor and a co-receptor (either CCR5 or CXCR4) on the surface of the host cell, facilitating its entry into the cell.
2. Reverse Transcription: Once inside the cell, the virus uses its reverse transcriptase enzyme to convert its RNA into DNA.
3. Integration: The viral DNA is then integrated into the host cell's genome with the help of the integrase enzyme. This process is known as HIV integration.

Clinical Significance

HIV integration is a key target for antiretroviral therapy (ART). Drugs that inhibit the integrase enzyme, known as integrase inhibitors, can prevent the integration of the viral DNA into the host cell's genome, thereby stopping the replication of the virus. Examples of integrase inhibitors include raltegravir, elvitegravir, and dolutegravir.

See Also

• HIV
• Integrase
• Antiretroviral therapy (ART)
• Integrase inhibitors

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia